e-prescribing Market – By Type, By Deployment Mode, By End Use, Global Forecast, 2025 to 2034

e-prescribing Market Size

The global e-prescribing market size valued at USD 2.6 billion in 2024 and is projected to exhibit 22.6% CAGR from 2025-2034. Growing adoption of digital health solutions and electronic health record, increasing awareness towards telemedicine services, increasing demand for reducing medication errors, and growing focus towards reducing healthcare fraud and abuse is driving the revenue growth in the market.
 

The increasing adoption of digital health solutions and electronic health records is driving the evolution of the market. These technologies streamline healthcare workflows, enhance patient outcomes, and improve the efficiency of prescription management, making them crucial in modern healthcare systems. e-prescribing systems are frequently integrated with electronic health records, providing healthcare providers with comprehensive patient information, including medical history, allergies, and current medications. This integration significantly reduces prescription errors by enabling real-time verification of potential drug interactions, contraindications, and appropriate dosages.
 

According to the U.S. governments “National Trends in Hospital and Physician Adoption of Electronic Health Record”, by 2021, close to 80% of office-based physicians (78%) and almost all non-federal acute care hospitals (96%) had adopted a certified Electronic Health Record (EHR) system, further driving the adoption of e-prescribing solutions and services.
 

e-prescribing is the process of electronically generating and transmitting a prescription from a healthcare provider to a pharmacy, using a secure, digital platform. This method replaces traditional handwritten prescriptions, offering numerous advantages for healthcare providers, pharmacies, and patients.
 

e-prescribing Market Trends

The market is evolving rapidly, driven by technological advancements, regulatory changes, and the increasing demand for efficient healthcare solutions.
 

• e-prescribing platforms are increasingly integrating AI algorithms to enhance clinical decision support. These algorithms recommend optimized dosages, flag potential drug interactions, and predict adverse reactions. Moreover, the growing adoption of telemedicine has established e-prescribing as a crucial component of remote patient care. During virtual consultations, healthcare providers can efficiently issue prescriptions, ensuring consistent and continuous care.
   
• Growing focus towards development and adoption of interoperability standards can be seen in the market. For example, Fast Healthcare Interoperability Resources (FHIR) is gaining traction towards becoming the standard for ensuring seamless communication between e-prescribing platforms, EHRs, and pharmacy systems. Unlike older standards (e.g., HL7 v2 or v3), FHIR uses modern web-based technologies like RESTful APIs, JSON, and XML, making it easier to implement and integrate into existing healthcare IT infrastructures.
   
• Vendors are increasingly customizing e-prescribing platforms to address the complexities of specialty drug management. Specialty drugs, characterized by their high costs and use in treating complex or chronic conditions such as cancer, autoimmune diseases, and rare disorders, require precise dosing, continuous monitoring, and prior authorization to ensure proper utilization.
   
• E-prescribing systems tailored for specialty drugs provide features to configure precise dosages based on patient-specific factors like weight or lab results and send alerts and reminders to ensure adherence to prescribed regimens. As a result, their use in specialized drug management has surged globally.
   

e-prescribing Market Analysis

Based on type, the market is segmented into solutions and services. The solutions segment is further bifurcated into integrated solutions and standalone solutions. Similarly, the services segment is bifurcated into support and maintenance services, implementation services, network services, and training and education services. Solutions segment dominate the market with a share of 68.9% in 2024.
 

• Rising demand for medication management among patients and providers, and growing focus towards reducing medication errors is driving the revenue growth in the solutions segment. E-prescribing solutions significantly reduce medication errors by automating the prescription process and integrating decision support tools.
   
• According to the Academy of Managed Care Pharmacy (AMCP), medication errors are one of the most prevalent types of medical errors, affecting at least 1.5 million people annually. Concerns related to medication errors are driving demand for efficient medication management solutions.
   
• Moreover, with the shift from fee-for-service to value-based care models, healthcare providers are incentivized to improve patient outcomes. E-prescribing solutions are offering enhanced medication management capabilities through supporting this shift by ensuring that the patients receive the right medication at the right time, improving adherence and overall health outcomes.
   

Based on deployment mode, the e-prescribing market is segmented into web and cloud-based solutions and on-premise solutions. The web and cloud-based solutions segment held a dominating share of 69.4% in the market in 2024.
 

• Web and cloud-based solutions eliminate the need for significant upfront investments in on-premises hardware and software. This makes them more affordable for healthcare providers, especially small and mid-sized practices.
   
• Additionally, web and cloud-based solutions provide advantages in terms of accessibility, scalability, and interoperability, which are crucial for healthcare providers and organizations looking to streamline medication management and improve patient safety. Owing to these benefits, the adoption of web and cloud-based solutions is increasing globally.
   

Based on end user, the e-prescribing market is segmented into hospitals, office-based physicians, and pharmacies. The hospitals segment dominated the market with a share of about 46.3% in the year 2024.
 

• Hospitals are increasingly adopting EHR systems. According to the U.S. governments “National Trends in Hospital and Physician Adoption of Electronic Health Record” during 2008 to 2021, the adoption of EHR in hospitals increased from 8% to 96%. As e-prescribing solutions are essential for integrating with these platforms. This seamless integration ensures that patient prescription data is readily available across different departments and healthcare providers, improving continuity of care and enabling better clinical decision-making.
   
• Additionally, hospitals are under increasing pressure to comply with healthcare regulations such as HIPAA (Health Insurance Portability and Accountability Act) and Meaningful Use standards.
   
• Features offered by e-prescribing software such as secure data transmission, audit trails, and compliance with local data protection regulations, are helping the large acute care centers such as hospitals to reduce the risk of medication errors and ensure patient data security, further driving the adoption of e-prescribing solutions and services across hospitals.
   

In 2024, the U.S. led the North American e-prescribing market, generating a revenue of about USD 950.3 million.
 

• The U.S. healthcare system has implemented significant regulatory measures to promote the adoption of electronic health records and e-prescribing. Key legislation, such as the Health Information Technology for Economic and Clinical Health (HITECH) Act and Meaningful Use incentives, has been instrumental in driving healthcare providers towards digitalizing prescription processes. These programs have offered financial incentives to hospitals and physicians.
   
• Additionally, significant investments and funding to promote digital health in the country are also contributing to the adoption of digital health solutions such as e-prescribing. According to the Statista, in 2022, New York city and San Francisco together invested about USD 9.2 billion in digital health. Availability of such fundings is driving the adoption of digital health technologies such as e-prescribing in the U.S.
   

The UK is set to see a robust expansion in its e-prescribing market from 2025 to 2034.
 

• The UK is a significant player in the market, largely due to its strategic initiatives and investments in digital health solutions within the National Health Service (NHS). The UK government has committed substantial funding to promote electronic prescribing across NHS hospitals, aiming to eliminate paper-based prescribing and improve patient safety.
   
• For instance, the UK government has allocated USD 11 million for e-prescribing initiatives. This funding represents the third allocation from a total of USD 98.7 million, aimed at enhancing patient care by accelerating the implementation of e-prescribing systems across the NHS over a three-year period.
   
• Furthermore, according to the British Medical Journal England witnesses 237 million medication errors annually at various stages of the medication process. Increasing concerns related to medication errors is driving the adoption of e-prescribing solutions and services across end users in the UK.
   

Japan's e-prescribing market is set for lucrative growth from 2024 to 2034.
 

• The Japanese government through its initiatives such as "Medical Digital Transformation (DX) Promotion Plan" is actively promoting digital health solutions, including e-prescribing, as part of its broader strategy to modernize the healthcare system and enhance operational efficiency. Regulations supporting digital records, such as Electronic Health Records, are driving the adoption of more comprehensive and interoperable digital systems, including e-prescribing in the country.
   
• Moreover, Japan's aging population, with its complex healthcare needs, drives the demand for more efficient medication management systems. e-prescribing provides a critical solution by streamlining the prescription process and improving the accuracy of medication administration.
   

Saudi Arabia's e-prescribing market is expected to witness substantial growth during the forecast period.
 

• Saudi Arabia's Vision 2030 prioritizes digital health transformation to enhance healthcare quality and efficiency. The government is making substantial investments in technological advancements to modernize the healthcare system. According to the World Economic Forum, in 2023, Saudi Arabia invested over USD 50 billion into various initiatives, notably digital health services, aiming to enhance efficiency, accessibility, and transparency in healthcare.
   
• Furthermore, the mandatory implementation of e-prescribing solutions has significantly increased their adoption. In 2019, the Ministry of Health introduced the Wasfaty system, which is now required for healthcare providers and pharmacies. This widespread adoption across hospitals, primary healthcare centers, and pharmacies has standardized and streamlined the prescription process.
   

e-prescribing Market Share

The market is fragmented, with large number of players operating across various regions and segments. The market includes both established companies and smaller, specialized vendors offering diverse solutions. Companies often focus on specific geographic markets due to regional regulatory requirements, differences in healthcare infrastructure, and local adoption rates.
 

Additionally, the rising adoption of new technologies such as mobile apps, AI-driven solutions, and enhanced interoperability features (e.g., FHIR) has led to the emergence of new players, intensifying competition. This influx of innovative startups contributes to the market's fragmentation, as these companies frequently provide specialized features or cater to niche markets.
 

e-prescribing Market Companies

Some of the eminent market participants operating in the e-prescribing industry include:

• AdvancedMD
• athenahealth
• CompuGroup Medical
• DrFirst.com
• eClinicalWorks
• Epic Systems Corporation
• GE Healthcare
• Greenway Health
• Henry Schein
• McKesson Corporation
• Medical Information Technology
• NextGen Healthcare
• Oracle Corporation
• Surescripts
• Veradigm 
   

e-prescribing Industry News:

• In October 2024, AdvancedMD announced its Fall 2024 product release that boasts over 30 updates across its practice management, EHR, and patient engagement platforms. Key additions include new prescription capabilities and eRx workflows, enhancements to their EHR solution aimed at boosting practice productivity and upgraded API features.
   
• In June 2024, CompuGroup Medical acquired the Norwegian software company Pridok. This strategic acquisition enhances CompuGroup Medical's market position in Northern Europe and establishes a foundation for continued development.
   

The e-prescribing market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Type

• Solutions      
  • Integrated solutions
  • Standalone solutions
• Services       
  • Support and maintenance services
  • Implementation services
  • Network services
  • Training and education services

Market, By Delivery Mode

• Web and cloud-based solutions
• On-premise solutions

Market, By End Use

• Hospitals
• Office-based physicians
• Pharmacies

The above information is provided for the following regions and countries:

• North America 
  • U.S.
  • Canada
• Europe 
  • Germany
  • UK
  • France
  • Spain
  • Italy
• Asia Pacific 
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America 
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa 
  • South Africa
  • Saudi Arabia
  • UAE